Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Expands Manufacturing Site In China As Part Of Its Global Restructuring Program

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Merck announced it would invest $162 million to expand its capacity in China by building a new manufacturing facility, shortly after the company detailed its plans to integrate its R&D, manufacturing and business operations worldwide
Advertisement

Related Content

Merck China CEO Michel Vounatsos And Emerging Markets R&D Senior VP RuiPing Dong On Provincial Management: An Interview With PharmAsia News
In China, A Province's Drastic Price Cut Model Is Being Modified To Fit A Nationwide System: A Look At The Anhui Model
Merck Powering Up In Emerging Markets Through Alliance And Pricing Strategies
Merck Powering Up In Emerging Markets Through Alliance And Pricing Strategies
Will China Healthcare Reform Drive Higher Rewards For Innovative Drugs?
"We Want To Shape Up Medical Treatment Paradigm Through Partnerships," Says Merck Asia-Pac President Ramesh Subrahmanian: An Interview With PharmAsia News (Part 1 of 2)
Merck Teams Up With Sinopharm On Vaccines As It Gears Up For Gardasil Approval In China
Merck Cuts 8 Research, 8 Manufacturing Sites As Part Of Schering Integration
Merck Cuts 8 Research, 8 Manufacturing Sites As Part Of Schering Integration
Merck Sharp & Dohme Launches Januvia In China To Join Race In Second-largest Diabetes Market
Advertisement
UsernamePublicRestriction

Register

SC075433

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel